Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 34
Filtrer
1.
Int J Equity Health ; 23(1): 161, 2024 Aug 15.
Article de Anglais | MEDLINE | ID: mdl-39148041

RÉSUMÉ

In this study, we evaluated and forecasted the cumulative opportunities for residents to access radiotherapy services in Cali, Colombia, while accounting for traffic congestion, using a new people-centred methodology with an equity focus. Furthermore, we identified 1-2 optimal locations where new services would maximise accessibility. We utilised open data and publicly available big data. Cali is one of South America's cities most impacted by traffic congestion. METHODOLOGY: Using a people-centred approach, we tested a web-based digital platform developed through an iterative participatory design. The platform integrates open data, including the location of radiotherapy services, the disaggregated sociodemographic microdata for the population and places of residence, and big data for travel times from Google Distance Matrix API. We used genetic algorithms to identify optimal locations for new services. We predicted accessibility cumulative opportunities (ACO) for traffic ranging from peak congestion to free-flow conditions with hourly assessments for 6-12 July 2020 and 23-29 November 2020. The interactive digital platform is openly available. PRIMARY AND SECONDARY OUTCOMES: We present descriptive statistics and population distribution heatmaps based on 20-min accessibility cumulative opportunities (ACO) isochrones for car journeys. There is no set national or international standard for these travel time thresholds. Most key informants found the 20-min threshold reasonable. These isochrones connect the population-weighted centroid of the traffic analysis zone at the place of residence to the corresponding zone of the radiotherapy service with the shortest travel time under varying traffic conditions ranging from free-flow to peak-traffic congestion levels. Additionally, we conducted a time-series bivariate analysis to assess geographical accessibility based on economic stratum. We identify 1-2 optimal locations where new services would maximize the 20-min ACO during peak-traffic congestion. RESULTS: Traffic congestion significantly diminished accessibility to radiotherapy services, particularly affecting vulnerable populations. For instance, urban 20-min ACO by car dropped from 91% of Cali's urban population within a 20-min journey to the service during free-flow traffic to 31% during peak traffic for the week of 6-12 July 2020. Percentages represent the population within a 20-min journey by car from their residence to a radiotherapy service. Specific ethnic groups, individuals with lower educational attainment, and residents on the outskirts of Cali experienced disproportionate effects, with accessibility decreasing to 11% during peak traffic compared to 81% during free-flow traffic for low-income households. We predict that strategically adding sufficient services in 1-2 locations in eastern Cali would notably enhance accessibility and reduce inequities. The recommended locations for new services remained consistent in both of our measurements.These findings underscore the significance of prioritising equity and comprehensive care in healthcare accessibility. They also offer a practical approach to optimising service locations to mitigate disparities. Expanding this approach to encompass other transportation modes, services, and cities, or updating measurements, is feasible and affordable. The new approach and data are particularly relevant for planning authorities and urban development actors.


Sujet(s)
Accessibilité des services de santé , Radiothérapie , Voyage , Humains , Colombie , Accessibilité des services de santé/statistiques et données numériques , Études transversales , Voyage/statistiques et données numériques , Radiothérapie/statistiques et données numériques , Radiothérapie/normes , Mégadonnées
4.
Rev. chil. endocrinol. diabetes ; 13(4): 159-165, 2020. tab, graf
Article de Espagnol | LILACS | ID: biblio-1123622

RÉSUMÉ

Introducción: El cáncer diferenciado de tiroides (CDT), es actualmente la neoplasia endocrina más frecuente. Su tratamiento estándar es la resolución quirúrgica, asociado a ablación con radioyodo (RI) según la clasificación propuesta por la American Thyroid Association (ATA). Las indicaciones y dosis de este último, han ido variando en los últimos años según avanzan las investigaciones en este ámbito. Objetivo: En el siguiente estudio se compararon las dosis de RI utilizadas previo y posterior a la implementación de las últimas guías de la ATA. Materiales y métodos: Estudio retrospectivo observacional de 70 pacientes con diagnóstico de CDT del Hospital Clínico de la Universidad de Chile entre 2012 y 2017. Se agruparon los pacientes en dos cohortes, los operados entre los años 2012-2015 y los 2016-2017 clasificándolos según riesgo ATA, TNM y riesgo de recurrencia. Se consignaron las dosis de RI utilizadas y se compararon entre las cohortes. Análisis estadístico: Mann Whithney. Resultados: Al comparar la dosis de RI entre ambas cohortes, según TNM y riesgo ATA, se obtuvo los siguientes resultados: los pacientes T1b de la cohorte 2012-2015 presentaron dosis de RI significativamente mayores que los de la cohorte 2016-2017; también se evidenció que en pacientes N0 hubo una diferencia estadísticamente significativa, mostrando una tendencia a disminuir la dosis de RI; además, en los pacientes de la cohorte 2012-2015 con riesgo ATA intermedio, se obtuvo que las dosis de RI fueron significativamente mayores que las utilizadas en la cohorte 2016-2017. Conclusión: Se concluye que las variaciones de las dosis de RI utilizadas en pacientes con CDT en un hospital universitario van acorde a las recomendaciones internacionales actuales, particularmente la publicación de la guía ATA 2015, aplicándose radioablación con menor dosis de RI. Dado este cambio, se ha evidenciado igualdad de efectos con dosis menores de RI y consecuentemente menos efectos adversos.


Introduction: Differentiated thyroid cancer (CDT) is currently the most frequent endocrine neoplasia. Its standard of care is surgical treatment, associated with radioiodine ablation (IR) according to the classification proposed by the American Thyroid Association (ATA). The indications and doses of the latter have changed in recent years as research in this area advances. Objective: In the following study, the doses of IR used before and after the implementation of the latest ATA guidelines were compared. Materials and methods: Retrospective observational study of 70 patients with a diagnosis of CDT from the Clinical Hospital of the University of Chile between 2012 and 2017. Patients were grouped into two cohorts, those surgically intervened between the years 2012-2015 and 2016-2017, classifying them according to ATA risk, TNM and recurrence risk. The IR doses used were reported and compared between the cohorts. Statistical analysis: Mann Whithney. Results: When comparing the IR dose between both cohorts, according to TNM and ATA risk, the following results were obtained: T1b patients in the 2012-2015 cohort had significantly higher IR doses than those in the 2016-2017 cohort; It was also evidenced that N0 patients showed a statistically significant tendency to decrease the IR dose; In addition, the 2012-2015 cohort with intermediate ATA risk, revealed IR doses significantly higher than those used in the 2016-2017 cohort. Conclusion: It is concluded that the variations in IR doses, used in patients with CDT in a university hospital, are in accordance with current international recommendations, particularly the publication of the ATA 2015 guidelines, applying radioablation with a lower dose of IR. Given this change, equality of effects has been evidenced with lower doses of IR and consequently fewer adverse effects.


Sujet(s)
Humains , Mâle , Femelle , Adulte , Adulte d'âge moyen , Dose de rayonnement , Radiothérapie/normes , Tumeurs de la thyroïde/radiothérapie , Endocrinologie/normes , Radio-isotopes de l'iode/administration et posologie , Thyroïdectomie/méthodes , Tumeurs de la thyroïde/chirurgie , Études rétrospectives , Études de cohortes , Guides de bonnes pratiques cliniques comme sujet , Appréciation des risques , Radiothérapie adjuvante , Endocrinologie/méthodes , Techniques d'ablation/méthodes , Radio-isotopes de l'iode/effets indésirables
6.
Clin Transl Oncol ; 20(3): 330-365, 2018 Mar.
Article de Anglais | MEDLINE | ID: mdl-28779421

RÉSUMÉ

PURPOSE: Total skin electron irradiation (TSEI) is a radiotherapy technique which consists of an homogeneous body surface irradiation by electrons. This treatment requires very strict technical and dosimetric conditions, requiring the implementation of multiple controls. Recently, the Task Group 100 report of the AAPM has recommended adapting the quality assurance program of the facility to the risks of their processes. MATERIALS AND METHODS: A multidisciplinary team evaluated the potential failure modes (FMs) of every process step, regardless of the management tools applied in the installation. For every FM, occurrence (O), severity (S) and detectability (D) by consensus was evaluated, which resulted in the risk priority number (RPN), which permitted the ranking of the FMs. Subsequently, all the management tools used, related to the TSEI process, were examined and the FMs were reevaluated, to analyze the effectiveness of these tools and to propose new management tools to cover the greater risk FMs. RESULTS: 361 FMs were identified, 103 of which had RPN ≥80, initially, and 41 had S ≥ 8. Taking this into account the quality management tools FMs were reevaluated and only 30 FMs had RPN ≥80. The study of these 30 FMs emphasized that the FMs that involved greater risk were related to the diffuser screen placement and the patient's position during treatment. CONCLUSIONS: The quality assurance program of the facility has been adapted to the risk of this treatment process, following the guidelines proposed by the TG-100. However, clinical experience continually reveals new FMs, so the need for periodic risk analysis is required.


Sujet(s)
Électrons/usage thérapeutique , Analyse des modes de défaillance et de leurs effets en soins de santé/méthodes , Radiothérapie/normes , Humains , Mycosis fongoïde/radiothérapie , Contrôle de qualité , Radiométrie , Radiothérapie/méthodes , Peau/effets des radiations , Tumeurs cutanées/radiothérapie
8.
Cien Saude Colet ; 19(1): 195-204, 2014 Jan.
Article de Portugais | MEDLINE | ID: mdl-24473616

RÉSUMÉ

This paper characterizes regulatory procedures applied by private health plan operators on their outpatient radiotherapy and chemotherapy services, especially via contracts, and outlines the health care providers' perception on regulation. The study relied on primary data, taking into consideration 638 hospitals and outpatient health care units with the services in question. A stratified random sample was selected, resulting in the inclusion of 54 units that are representative of the population, excluding hospitals that only provide radiotherapy. Private chemotherapy services are largely funded by health insurance plans (75.0%), while radiotherapy services are predominantly covered by the public health system (49.0%). Contracts are not applied by third part payers, in their potential, as regulatory and health care coordination instruments. The mechanisms of regulation applied by third part payers are centered on services use control and administrative aspects. It is recognized the need of adjustments for a health care quality focus, and contracts may contribute in this sense.


Sujet(s)
Traitement médicamenteux/normes , Organismes de planification de la santé , Radiothérapie/normes , Brésil , Études transversales , Humains
10.
Radiol. bras ; Radiol. bras;45(2): 83-86, mar.-abr. 2012. ilus, tab
Article de Portugais | LILACS | ID: lil-624456

RÉSUMÉ

OBJETIVO: Estimar a dose extracraniana nos olhos, tireoide, tórax e pelve em pacientes submetidos a radiocirurgia com acelerador linear de 6 MV. MATERIAIS E MÉTODOS: Foram avaliados 11 pacientes com tumores cerebrais primários (7 pacientes) e secundários (4 pacientes), sendo que dois destes apresentavam duas lesões. Para a estimativa da dose extracraniana, foram utilizados dosímetros termoluminescentes. Foram utilizados cones de 1,50 a 3,75 cm e as doses de radiação variaram de 1300 a 2000 cGy. RESULTADOS: A idade média dos pacientes foi de 52 anos, sendo 63,6% do sexo feminino e 36,4% do sexo masculino. As localizações das lesões foram: nervo acústico direito (1), frontal (2), parietal (5), occipital direito (1), cerebelar (2) e parassagitais (2). Os valores médios das doses recebidas na região entre os olhos foram de 5,1 cGy; no olho direito, de 4,8 cGy; no olho esquerdo, de 6,5 cGy; na tireoide, de 4,2 cGy; no tórax, de 1,65 cGy; e na pelve, de 0,45 cGy. CONCLUSÃO: Estes resultados mostram que embora as doses não ultrapassem os limites de tolerância para ocorrência da opacidade do cristalino, é importante que os médicos radioterapeutas considerem os riscos de dose de radiação nessas regiões durante o planejamento de procedimentos de radiocirurgia craniana.


OBJECTIVE: To estimate extracranial doses on eyes, thyroid, chest and pelvis in patients submitted to radiosurgery with 6 MV linear accelerator. MATERIALS AND METHODS: The present study evaluated 11 patients, 7 of them with primary, and 4 with secondary brain tumors. In the latter group, 2 patients had two lesions. Thermoluminescent dosimeters were utilized to estimate the extracranial dose. Radiosurgery cones ranges between 1.50 and 3.75 cm and doses between 1300 and 2000 cGy. RESULTS: Mean patients' age was 52 years, and 63.6% of them were women and 36.4%, men. Lesion locations were the following: right acoustic nerve (1), frontal (2), parietal (5), right occipital (1), cerebellum (2) and parasagittal (2). Mean received doses were the following: 5.1 cGy between the eyes; 4.8 cGy in the right eye; 6.5 cGy in the left eye; 4.2 cGy in the thyroid; 1.65 cGy in the chest; and 0.45 cGy in the pelvis. CONCLUSION: The results demonstrate that that although the eye doses do not exceed the tolerance limits for occurrence of lens opacity, it is important that the risks associated with radiation doses are taken into consideration by radiotherapists in the planning of cranial radiosurgery procedures.


Sujet(s)
Humains , Mâle , Femelle , Adulte , Adulte d'âge moyen , Sujet âgé de 80 ans ou plus , Tumeurs du cerveau/radiothérapie , Rayonnement ionisant , Radiochirurgie , Radiométrie/normes , Radiothérapie/normes , Oeil , Accélérateurs de particules , Pelvis , Thorax , Glande thyroide
11.
Appl Radiat Isot ; 67(1): 174-7, 2009 Jan.
Article de Anglais | MEDLINE | ID: mdl-18835722

RÉSUMÉ

This work aims to calculate the conversion coefficients from air kerma to ambient dose equivalent, H*(10)/K(air) for photon beams produced by linear accelerators, such as the Clinac-4, Clinac-6, Clinac-18 and Clinac-2500, after transmission through primary barriers of radiotherapy treatment rooms. Concrete walls of thickness 1.0, 1.5 and 2.0m were irradiated with 30cmx30cm primary beam spectra. The transmitted spectra were calculated to obtain the conversion coefficients for beams found in radiotherapy services. The calculations were done using the MCNP-4B Monte Carlo code. The results indicate the need to use a factor of about 1.20 to obtain the ambient dose equivalent for radiation surveys near primary barriers using instruments calibrated in air kerma.


Sujet(s)
Air , Accélérateurs de particules/normes , Dose de rayonnement , Radiothérapie/instrumentation , Calibrage , Méthode de Monte Carlo , Photons , Radiothérapie/normes
13.
Rio de Janeiro; INCA; 2008. 35 p.
Monographie de Portugais | Inca | ID: biblio-1116964

RÉSUMÉ

Relatórios do Serviço de Qualidade em Radiações Ionizantes, dos Programas de Qualidade em Radioterapia e de Qualidade em Mamografia do Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)


Sujet(s)
Humains , Contrôle de qualité , Radiothérapie/normes , Mammographie/normes
14.
Rev. panam. salud pública ; 20(2/3): 143-150, ago.-sept. 2006. ilus
Article de Espagnol | LILACS | ID: lil-441029

RÉSUMÉ

La experiencia acumulada en más de un siglo de práctica de radioterapia ha puesto de manifiesto su importancia no solamente para la atención paliativa de una parte de los casos de cáncer, sino principalmente para la curación de una proporción aun mayor de esos pacientes. Teniendo en cuenta la evolución tecnológica, el acceso cada vez mayor que tienen los países en desarrollo a estos métodos y la cobertura actual en América Latina, los esfuerzos en esta área se deben dirigir a mejorar la calidad de los servicios y de los centros de radioterapia ya instalados. Para ello se debe completar su parque tecnológico, ampliar los servicios que prestan y cumplir los requerimientos mínimos de calidad establecidos para instalaciones del nivel 2. Cada centro debe estar en condiciones de realizar todas las etapas del proceso de radioterapia -desde la simulación hasta la verificación del tratamiento y el seguimiento de los pacientes- con una calidad adecuada (nivel 2). Para ello deben contar con la tecnología necesaria y con el personal debidamente capacitado. Los esfuerzos cooperativos en la Región deben tener también como prioridad contribuir a que los países adopten guías nacionales de tratamiento que contemplen todas las etapas del proceso de radioterapia y fomentar la puesta en marcha de programas validados de garantía de la calidad.


The cumulative experience gathered over more than a century of practice of radiotherapy has demonstrated the latter's importance not only for the palliative treatment of a fraction of cancer cases, but mainly for the curative treatment of an even greater proportion of such cases. In light of the changes in technology, the ever-increasing access developing countries to such technology, and its current coverage in Latin America, any efforts in this area should be aimed at improving the quality of the radiotherapy services and centers that are already in place. This involves developing their technological assets to the fullest, expanding their services, and complying with the minimum quality requirements established for second-level facilities. Each center should be equipped to carry out all stages of the radiotherapy process, from simulation through treatment verification and patient follow-up, with a high level of quality (level 2). To achieve this, it should possess the necessary technology and properly-trained staff that are required for the purpose. Collaborative efforts in the Region should also prioritize helping countries implement national treatment standards for all stages of the radiotherapy process and promoting the implementation of validated quality assurance programs.


Sujet(s)
Humains , Radio-oncologie/normes , Radiothérapie/normes , Besoins et demandes de services de santé , Amérique latine
15.
Acta Neurochir (Wien) ; 148(8): 865-71; discussion 871, 2006 Aug.
Article de Anglais | MEDLINE | ID: mdl-16791430

RÉSUMÉ

OBJECTIVE: Pure pineal germinomas have been rarely reported in girls. Gender incidence and differences of pure pineal germinomas are not well known. The authors report a series of pure pineal germinoma and its gender characteristic is reviewed. METHODS AND RESULTS: Of a total of 50 germ cell tumors operated on between 1988 and 2004 we found 26 cases (median age at diagnosis, 12 years) of pineal germ cell tumors. Of these, 14 cases (male/female ratio: 13/1) were pure pineal germinomas, and 12 cases (male/female ratio: 12/0) were non-germinoma germ cell tumors. In pure pineal germinomas, the main clinical presentations were intracranial hypertension and cranial nerve dysfunction. Imaging studies disclosed a homogeneous type of tumor (n = 10) and associated hydrocephalus (n = 6). Cases were managed with biopsy and subsequent radiation therapy and chemotherapy. After a follow up of 10 years, pure germinoma cases have no neurological deficits and tumor recurrence. The literature on gender incidence of pure pineal germinomas is analyzed and possible causes are discussed. CONCLUSIONS: Although rare, pure pineal germinoma can be found in female subjects. On the basis of the literature review, the male/female ratio in cases of pure pineal germinoma is between 5:1 and 22:1 (mean 14:1). In our series, the male/female ratio was 13:1.


Sujet(s)
Germinome/épidémiologie , Glande pinéale/anatomopathologie , Pinéalome/épidémiologie , Adolescent , Protocoles de polychimiothérapie antinéoplasique/usage thérapeutique , Argentine/épidémiologie , Dérivations du liquide céphalorachidien/normes , Dérivations du liquide céphalorachidien/statistiques et données numériques , Enfant , Atteintes des nerfs crâniens/diagnostic , Atteintes des nerfs crâniens/étiologie , Atteintes des nerfs crâniens/physiopathologie , Traitement médicamenteux/normes , Traitement médicamenteux/statistiques et données numériques , Femelle , Germinome/complications , Germinome/diagnostic , Humains , Hydrocéphalie/diagnostic , Hydrocéphalie/étiologie , Hydrocéphalie/physiopathologie , Hypertension intracrânienne/diagnostic , Hypertension intracrânienne/étiologie , Hypertension intracrânienne/physiopathologie , Imagerie par résonance magnétique , Mâle , Récidive tumorale locale/prévention et contrôle , Récidive tumorale locale/thérapie , Glande pinéale/imagerie diagnostique , Glande pinéale/physiopathologie , Pinéalome/complications , Pinéalome/diagnostic , Radiothérapie/normes , Radiothérapie/statistiques et données numériques , Répartition par sexe , Tomodensitométrie , Résultat thérapeutique
16.
Rev Panam Salud Publica ; 20(2-3): 143-50, 2006.
Article de Espagnol | MEDLINE | ID: mdl-17199909

RÉSUMÉ

The cumulative experience gathered over more than a century of practice of radiotherapy has demonstrated the latter's importance not only for the palliative treatment of a fraction of cancer cases, but mainly for the curative treatment of an even greater proportion of such cases. In light of the changes in technology, the ever-increasing access developing countries to such technology, and its current coverage in Latin America, any efforts in this area should be aimed at improving the quality of the radiotherapy services and centers that are already in place. This involves developing their technological assets to the fullest, expanding their services, and complying with the minimum quality requirements established for second-level facilities. Each center should be equipped to carry out all stages of the radiotherapy process, from simulation through treatment verification and patient follow-up, with a high level of quality (level 2). To achieve this, it should possess the necessary technology and properly-trained staff that are required for the purpose. Collaborative efforts in the Region should also prioritize helping countries implement national treatment standards for all stages of the radiotherapy process and promoting the implementation of validated quality assurance programs.


Sujet(s)
Radio-oncologie/normes , Radiothérapie/normes , Besoins et demandes de services de santé , Humains , Amérique latine
17.
Clin Transl Oncol ; 7(2): 47-54, 2005 Mar.
Article de Espagnol | MEDLINE | ID: mdl-15899208

RÉSUMÉ

Prescribed total radiation dose should be administered within in a specific time-frame and delays in commencing treatment and/or unplanned interruptions in radiation delivery are unacceptable because, in certain cancer sites, treatment-time prolongation can have a deleterious effect on local tumour control, and on patient outcomes. The present review evaluated the causes of initial treatment delays as well as interruptions in the scheduled radiotherapy. The literature search highlighted a significant concern in avoiding treatment-time prolongation in head and neck, cervix, breast and lung cancer. Among the causes involved in delay in radiotherapy commencement factors such as waiting lists, lack of material and human resources, and an increase complexity in planning, simulation and verification are highlighted. Most authors recommend radiotherapy commencement as soon as possible in radical (exclusive irradiation with active tumour present) and palliative situations with a maximum delay of no more than 6 to 8 weeks in the case of adjuvant radiotherapy (post-resection) programs. Interruptions during the course of treatment include: planned unit maintenance and servicing, acute patient toxicity or unexpected malfunction of linear accelerators; this last feature has the most deleterious effect on patients as well as radiotherapy practitioners. Interruptions that impact on the programmed time-course for radiotherapy needs to be compensated-for so as assure the biological equivalence in treatment efficacy with respect to cancer site and stage.


Sujet(s)
Radiothérapie/méthodes , Radiothérapie/normes , Humains , Facteurs temps
18.
Cad Saude Publica ; 20 Suppl 2: S256-67, 2004.
Article de Portugais | MEDLINE | ID: mdl-15608939

RÉSUMÉ

Radiation therapy services provide essential therapeutic procedures for cancer, one of the main causes of population morbidity and mortality. Despite their importance in the health system and their potential risks due to the use of ionizing radiation, there are few studies on such services. We evaluated compliance with technical standards for radiological protection in radiation therapy services in Sao Paulo State, Brazil. Forty-nine services were studied in 2000 through interviews with technical staff. Typologies of performance profiles focusing on structure and process variables were constructed and services compared. Important differences were observed in the services' positions in the health care system, level of complexity, and geographic distribution, with better average performance in structural conditions but very inadequate performance in patient protection, indicating the need for more effective health surveillance.


Sujet(s)
Radioprotection (spécialité)/normes , Services de santé/normes , Radioprotection/normes , Radiothérapie/normes , Brésil , Radioprotection (spécialité)/législation et jurisprudence , Humains , Entretiens comme sujet , Surveillance de la population , Radioprotection/législation et jurisprudence , Normes de référence , Enquêtes et questionnaires
20.
Säo Paulo; s.n; 2001. 291 p. ilus.
Thèse de Portugais | Sec. Est. Saúde SP, SESSP-ACVSES | ID: biblio-1072394

RÉSUMÉ

Vigilância sanitária, no texto da Constituiçäo Brasileira de 1988, que define a saúde como um direito de todos e dever do Estado, e na Lei N. 8.080/90, que regulamenta as açöes e serviços de saúde, ganha o reconhecimento de seu papel de controle dentro do sistema de saúde, como um conjunto de açöes e resposta aos riscos à saúde gerados no processo de produçäo econômico e social. Apesar dessa notória importância, paradoxalmente, a produçäo nacional nesta matéria é escassa. O programa de vigilância sanitária de serviços de saúde exercido nos serviços de radioterapia no estado de Säo Paulo é o objeto do presente estudo, um recorete específico sobre a organizaçäo desta prática no cumprimento de seus objetivos e resultados. Trata-se de uma avaliaçäo de programa, na linha da pesquisa qualitativa, centrada na avlaiaçäo de efetividade, isto é, da performance de suas equipes e das conformidades esperadas nos estabelecimentos de reconhecido alto potencial de risco, no caso, aqueles que emrpegam a radiaçäo ionizante para fins de radioterapia, buscando-se detectar o grau de adoçäo dos procedimentos de proteçäo radiológica estabelecidos em normas técnicas e leis, em relaçäo aos pacientes, profissionais e público. Tipologias de classificaçäo das vigilâncias sanitárias por perfis de performances e dos serviços de radioterpai por resultados. Os resultados encontrados apontam, näo apenas, para as características que interferem em seu desempenho, nos resultados positivos ou negativos e sobre as relaçöes causais entre vigiar s e ser vigiado, mas permitem, como um dos principais produtos do estudo, a sistematizaçäo de um método que pode ser disponibilizado para vigilância sanitária como incentivo à reflexäo e à avaliaçäo de suas formas de atuar e do alcance seus objetivos


Sujet(s)
Administration de la santé publique/méthodes , Analyse et exécution des tâches , Évaluation de programme/méthodes , Études transversales , Facteurs de risque , Rayonnement ionisant , Radiothérapie/normes , Surveilance de Santé , Radiothérapie/tendances
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE